As of 3:59pm ET
| -0.75 / -3.10%|
The 9 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 45.00 and a low estimate of 25.00. The median estimate represents a +40.72% increase from the last price of 23.45.
The current consensus among 11 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since January, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.